(NASDAQ: KRRO) Korro Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.67%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34%.
Korro Bio's earnings in 2026 is -$117,260,000.On average, 12 Wall Street analysts forecast KRRO's earnings for 2026 to be -$101,152,702, with the lowest KRRO earnings forecast at -$212,718,500, and the highest KRRO earnings forecast at -$46,188,284. On average, 9 Wall Street analysts forecast KRRO's earnings for 2027 to be -$109,561,061, with the lowest KRRO earnings forecast at -$201,552,545, and the highest KRRO earnings forecast at -$36,344,879.
In 2028, KRRO is forecast to generate -$126,846,512 in earnings, with the lowest earnings forecast at -$246,781,728 and the highest earnings forecast at -$43,159,544.